右心室大小和功能的回声心脏学参数与持久左心室辅助器件植入后与右心力衰竭相关 - 一个系统性审查和元分析
Jia Cheng Kevyn Chai1,2, Jia Le Chew1, Anjalee Amarasekera3,4
1Department of Cardiology, Blacktown Hospital, Western Sydney Local Health District, Blacktown, New South Wales, Australia.
Echocardiography (Mount Kisco, N.Y.)
|March 4, 2025
概括
右心室 (RV) 衰竭是长期左心室辅助装置 (D-LVAD) 植入后的常见并发症. 响应心脏图像参数如TAPSE和RVEDD显示出预测这些患者的RV衰竭的潜力.
科学领域:
- 心脏病学 心脏病学
- 医疗成像医学成像
- 心血管外科心血管外科
背景情况:
- 晚期发病的右心室衰竭是耐用左心室辅助装置 (D-LVAD) 植入后的一个已知的并发症.
- 胸外心声学 (TTE) 是监测RV状态的主要成像工具,但由于设备效应,解释变得复杂.
- 缺乏对D-LVAD患者TTE解释的具体指导方针,阻碍了对VR大小和功能的准确评估.
研究的目的:
- 评估TTE参数的诊断和预后效用,以检测D-LVAD后晚期发作的RV故障.
- 评估D-LVAD植入如何影响RV大小和通过TTE测量的缩功能.
- 确定特定的TTE指标,可以预测RV故障的发展.
主要方法:
- 在医学数据库中对2003年1月至2023年8月期间发表的研究进行了系统的文献搜索.
- 对9项研究 (627名患者) 和3项研究 (175名患者) 的元分析评估了各种结构和功能TTE参数.
- 对D-LVAD患者的TTE参数与世界心声协会 (WASE) 参考值进行比较.
主要成果:
- 与WASE规范相比,患有D-LVAD的患者表现出基线RV扩张 (RVEDD) 和缩功能降低 (TAPSE,RVFAC,RVEF).
- 三 annular 平面缩外流 (TAPSE) 与没有 RV 失效积极相关.
- RV终端透析直径 (RVEDD) 与没有RV失败有负相关性,这表明与RV失败的发展有联系.
结论:
- 患有D-LVAD的患者通常存在VR扩张和缩功能受损.
- TAPSE和RVEDD与RV故障发展有显著的关联,表明它们作为预后标记物的潜力.
- 需要进行进一步的研究,以确定用于VR评估的特定植入后TTE参考值.
相关概念视频
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...


